Effects of (±)-Idazoxan Alone and in Combination with L-DOPA Methyl Ester in MPTP-Induced Hemiparkinsonian Monkeys
- 1 January 2003
- journal article
- research article
- Published by Taylor & Francis in Receptors and Channels
- Vol. 9 (5) , 335-338
Abstract
The effects of a combination of the f 2 -adrenergic receptor antagonist ( - )-idazoxan with L-DOPA methyl ester were examined in three of four female adult monkeys ( Macaca nemestrina ) rendered hemiparkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). ( - )-Idazoxan (0.16, 0.63, and 1.0 mg/kg) was given i.m. 10 min before L-DOPA methyl ester (12.5 mg/kg). ( - )-Idazoxan reduced the maximum peak of contralateral circling elicited during the first hour following injection of L-DOPA methyl ester, but prolonged the duration of the circling response up to 50% ( p < 0.05). The data support a role for f 2 -adrenergic receptor mechanisms in modulating the effects of L-DOPA on nigrostriatal dopamine function in the MPTP monkey model of hemiparkinsonism.Keywords
This publication has 4 references indexed in Scilit:
- In vitroandin vivoapproaches to the characterization of the α2‐adrenoceptorJournal of Autonomic Pharmacology, 1999
- The ?2-adrenergic receptor antagonist idazoxan reduces dyskinesia and enhances anti-parkinsonian actions ofL-dopa in the MPTP-lesioned primate model of Parkinson's diseaseMovement Disorders, 1999
- Effects of Alpha-2 Adrenoceptor Agonists and Antagonists on Circling Behavior in Rats with Unilateral 6-Hydroxydopamine Lesions of the Nigrostriatal PathwayThe Journal of Pharmacology and Experimental Therapeutics, 1999
- Effects of Noradrenergic Lesions on MPTP/MPP+Kinetics and MPTP-Induced Nigrostriatal Dopamine DepletionsThe Journal of Pharmacology and Experimental Therapeutics, 1997